Clinical Immunology Service

Organisational unit: Department

21 - 30 out of 57Page size: 10
Sort by: Start date

Research Projects

  1. Exploring the effect of exercise on immune function and beta cell health in patients with type 1 diabetes

    Parth Narendran, John Campbell & Mark Drayson

    UHB NHS TRUST

    1/10/14 → 30/09/18

    Project: Research

  2. Optimising Renal outcome in Myeloma renal failure

    Mark Drayson

    OXFORD UNIVERSITY HOSPITALS NHS TRUST

    1/08/14 → 31/12/19

    Project: Research

  3. Modernising and Improving the identification and management of plasma cell cancers

    & Mark Drayson

    SERASCIENCE LTD

    13/02/14 → 12/02/16

    Project: Industry

  4. Specialst Programme : Aldo-keto reductases (AKRs), BaP Therapgy and drug redeployment strategies for accelerating thraphy development for haematological cancers

    Farhat Khanim & Mark Drayson

    BLOODWISE

    1/10/13 → 31/12/19

    Project: Research

  5. Redirected Viral Immunotherapy for Acute Myeloid Leukaemia

    Mark Cobbold, Sylvie Freeman, Pamela Kearns & Victoria Weston

    BLOODWISE

    9/09/13 → 8/09/16

    Project: Research

  6. MRC CIC - Unique Multiplexed Assays to Identify and Measure Monoclonal Immunoglobulin (MIg) for the Diagnosis and Management of Plasma Cell Dyscrasias (PCDs); Optimisation and Clinical Validation of Laboratory-Based Assays

    John Campbell & Mark Drayson

    MEDICAL RESEARCH COUNCIL, SERASCIENCE LTD

    13/05/13 → 29/02/16

    Project: Research

  7. A pharmacological database for enabling implementation of Accelerated Drug Redeployment Programme (ADReP)

    Farhat Khanim, Nicholas Barnes, Christopher Bunce & Mark Drayson

    MEDICAL RESEARCH COUNCIL

    8/04/13 → 7/12/13

    Project: Research Councils

  8. Characterising and Immunologically Targeting the Phosphoproteome in Myeloid Leukaemia

    Mark Cobbold, Charles Craddock, Sylvie Freeman & Manoj Raghavan

    BLOODWISE

    1/10/12 → 30/09/16

    Project: Research

  9. BaP: Single Arm Phase II trial assessing the safety, compliance and activity, of Bezafibrate and medroxyProgesterone acetate (BaP) as non-toxic therapy against myeloid and lymphoid cancers

    Mark Drayson, Christopher Bunce & Keith Wheatley

    UHB CHARITABLE FUNDS

    12/04/12 → 31/12/15

    Project: Research

  10. Top Jabs - Improving Vaccination Responses in Older Adults

    Kai Toellner, Anna Whittaker, Janet Lord, Jeremy Tomlinson, Mark Drayson & Peter Lane

    MEDICAL RESEARCH COUNCIL

    1/10/11 → 31/01/15

    Project: Research Councils

Previous 1 2 3 4 5 6 Next